Cargando…
Immunomodulators: interleukins, interferons, and IV immunoglobulin
The outstanding progress in immunology and the development of new technologies have resulted in the introduction of new immunotherapies, the so-called “immunomodulators”, for autoimmune diseases, inflammatory disorders, allograft rejection, and cancer. These immunomodulators comprise recombinant cyt...
Autores principales: | Roelofs, Joris J., Abramowicz, Daniel, Florquin, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120840/ http://dx.doi.org/10.1007/978-0-387-84843-3_29 |
Ejemplares similares
-
Renal amyloidosis: validation of a proposed histological scoring system in an independent cohort
por: Hoelbeek, Joris J, et al.
Publicado: (2020) -
Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy.
por: von Rohr, A., et al.
Publicado: (1993) -
Bisphosphonate nephropathy: A case series and review of the literature
por: de Roij van Zuijdewijn, Camiel, et al.
Publicado: (2021) -
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
por: Velikova, Tsvetelina, et al.
Publicado: (2023) -
Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-γ()
por: Saravolac, E.G., et al.
Publicado: (1996)